tirzepatide in pregnancy and Pregnancy: Safety, Risks, and What Doctors Say tirzepatide pregnancy safety studies GLP-1

The result is fewer side effects than the other GLP-1 agonists, along with more weight loss and better insulin control, Skelley notes

GLP-1 medications alter the environment in which gut bacteria operate, and early research suggests this can shift microbial populations in ways that may contribute to digestive symptoms

Dehydration may also contribute to muscle cramping and generalized musculoskeletal discomfort

Taylor, R., Al-Mrabeh, A

Specifically, GST was shown to be an endogenous inhibitor of c-Jun N-terminal kinase 1 (JNK1), a kinase involved in stress response, apoptosis, and cellular proliferation (Adler et al ., 1999

The FDA does not approve compounded medications or review them before marketing in the same way it reviews approved drugs